Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec 27;18(1):41.
doi: 10.3390/ijms18010041.

Osteogenic Differentiation in Healthy and Pathological Conditions

Affiliations
Review

Osteogenic Differentiation in Healthy and Pathological Conditions

Maria Teresa Valenti et al. Int J Mol Sci. .

Abstract

This review focuses on the osteogenic differentiation of mesenchymal stem cells (MSC), bone formation and turn-over in good and ill skeletal fates. The interacting molecular pathways which control bone remodeling in physiological conditions during a lifelong process are described. Then, alterations of the molecular pathways regulating osteogenesis are addressed. In the aging process, as well as in glucocorticoid-induced osteoporosis, bone loss is caused not only by an unbalanced bone resorption activity, but also by an impairment of MSCs' commitment towards the osteogenic lineage, in favour of adipogenesis. Mutations affecting the expression of key genes involved in the control of bone development occur in several heritable bone disorders. A few examples are described in order to illustrate the pathological consequences of perturbation in different steps of osteogenic commitment, osteoblast maturation, and matrix mineralization, respectively. The involvement of abnormal MSC differentiation in cancer is then discussed. Finally, a brief overview of clinical applications of MSCs in bone regeneration and repair is presented.

Keywords: Pigment Epithelium Derived Factor (PEDF); Runt-related transcription factor 2 (RUNX2); Wingless-Type MMTV Integration Site Family (WNT); bone; mesenchymal stem cells; microRNAs; osteoblasts; osteopenia; remodeling.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of cell types and major regulators of the molecular pathways involved in osteoblastogenesis and bone formation.
Figure 2
Figure 2
Defects in bone mineralization due to the lack of PEDF. (A) Iliac bone section of a patient affected by OI type VI. A large amount of unmineralized osteoid (in red) and resorption lacunae are visible. (B) Bone section under polarized light. Black arrows point to the so called “fish-scale” pattern (magnification 200×) (Reproduced from J. Bone Miner. Res. 2012, 50, 343–349, with permission of the American Society for Bone and Mineral Research). The insert in (B) shows an enlargement of fish scale (2000×).

References

    1. Berendsen A.D., Olsen B.R. Bone development. Bone. 2015;80:14–18. doi: 10.1016/j.bone.2015.04.035. - DOI - PMC - PubMed
    1. Atkins G.J., Findlay D.M. Osteocyte regulation of bone mineral: A little give and take. Osteoporos. Int. 2012;23:2067–2079. doi: 10.1007/s00198-012-1915-z. - DOI - PubMed
    1. Wang Y., Li Y.P., Paulson C., Shao J.Z., Zhang X., Wu M., Chen W. Wnt and the Wnt signaling pathway in bone development and disease. Front. Biosci. 2014;19:379–407. doi: 10.2741/4214. - DOI - PMC - PubMed
    1. Li M., Li Y., Deng W., Zhang Z., Deng Z., Hu Y., Xia W., Xu L. Chinese bone turnover marker study: Reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender. PLoS ONE. 2014;9:e103841. doi: 10.1371/journal.pone.0103841. - DOI - PMC - PubMed
    1. Li F., Song N., Tombran-Tink J., Niyibizi C. Pigment epithelium-derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells. Stem Cells. 2013;31:2714–2723. doi: 10.1002/stem.1505. - DOI - PubMed

LinkOut - more resources